Related Experiment Videos
Does type II diabetes predispose to retinal vein occlusion?
P M Dodson1, C G Clough, S M Downes
1Department of Diabetes, Dudley Road Hospital, Birmingham, U.K.
European Journal of Ophthalmology
|July 1, 1993
Summary
Retinal vein occlusion (RVO) in diabetics is strongly linked to hypertension and hyperlipidaemia. These conditions, not microvascular complications, are key factors in RVO development and prevention.
Area of Science:
- Ophthalmology
- Diabetology
- Vascular Medicine
Background:
- Retinal vein occlusion (RVO) is a recognized complication in diabetic patients.
- The exact etiology of RVO in diabetes remains unclear, with potential links to other microvascular complications.
- In non-diabetic individuals, RVO is commonly associated with hypertension and hyperlipidaemia.
Purpose of the Study:
- To investigate the underlying medical conditions and aetiology of RVO in type II diabetic patients.
- To compare the prevalence of risk factors in diabetic patients with RVO versus a matched diabetic control group.
Main Methods:
- A case-control study involving fifty type II diabetic patients with RVO and fifty matched diabetic controls.
- Comparison of demographic data, medical history, prevalence of hypertension, hyperlipidaemia, and microvascular complications between the two groups.
Main Results:
- Diabetic patients with RVO exhibited a significantly higher prevalence of hypertension (72% vs. 32%) compared to controls.
- A trend towards increased hyperlipidaemia was observed in the RVO group (54% vs. 36%).
- Hypertension was present in 80% of diabetic patients with branch RVO (BRVO); microvascular complications were more frequent in controls.
Conclusions:
- Hypertension and hyperlipidaemia are identified as the primary underlying medical conditions associated with RVO in diabetic patients.
- These vascular risk factors appear to play a significant role in the aetiology of RVO in diabetics, similar to non-diabetics.
- RVO in diabetics, particularly type II, is not associated with existing microvascular complications, highlighting the importance of managing hypertension and hyperlipidaemia for prevention.